These include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...

As part of expanding the injectable business, Aurobindo is setting up a dedicated injectable facility in Vizag for the EU and other global ...

The NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...

In an interview to ET, Chirag Patel, Co-Chief Executive Officer of Amneal said that the company would hit the Indian market with its first ...

Apart from Dolly Khanna, Mukul Agrawal, another renowned value investor, increased his holding in the company to 2.34 per cent from 1.95 pe...

In more recent times trade and investment and Indian diaspora in Ireland are bringing the two countries closer. “Trade and investment also ...

Resolution of the US drug price fixing probe will remove a major overhang on the stock.

Nomura has a buy rating on Dr Reddy’s Laboratories with a target price of Rs 3,200.

Investors remained cautious, looking for fresh triggers after the end of earnings season.

Here is a list of top stocks that are likely to be in focus in today's trading session.

Under the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...

The stock had rallied in previous session following reports that big national and international companies are in fray to buy company’s inje...

Lupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...

Carlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.

The Finance Ministry has cleared 20 FDI proposals including 6 in the pharma sector envisaging a total inflow of Rs 988.3 crore.

UCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.

Indoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...